TSPO and early-onset autosomal dominant Alzheimer disease: Our results suggest that [18F]DPA714, a molecular probe targeting TSPO, has great potential in monitoring microglia activation and neuroinflammation and discovering the best time point of anti-inflammatory therapy for Alzheimer's disease.